MY184577A - Method for the preparation of triazole compounds - Google Patents

Method for the preparation of triazole compounds

Info

Publication number
MY184577A
MY184577A MYPI2014703274A MYPI2014703274A MY184577A MY 184577 A MY184577 A MY 184577A MY PI2014703274 A MYPI2014703274 A MY PI2014703274A MY PI2014703274 A MYPI2014703274 A MY PI2014703274A MY 184577 A MY184577 A MY 184577A
Authority
MY
Malaysia
Prior art keywords
preparation
morpholin
triazol
pyrazol
pyrimidin
Prior art date
Application number
MYPI2014703274A
Other languages
English (en)
Inventor
Militzer Hans-Christian
Eggert Johannes
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48325714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY184577(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of MY184577A publication Critical patent/MY184577A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MYPI2014703274A 2012-05-08 2013-05-06 Method for the preparation of triazole compounds MY184577A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12167152 2012-05-08
PCT/EP2013/059418 WO2013167552A1 (de) 2012-05-08 2013-05-06 Verfahren zur herstellung von triazol-verbindungen

Publications (1)

Publication Number Publication Date
MY184577A true MY184577A (en) 2021-04-06

Family

ID=48325714

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014703274A MY184577A (en) 2012-05-08 2013-05-06 Method for the preparation of triazole compounds

Country Status (35)

Country Link
US (1) US10301289B2 (https=)
EP (1) EP2847183B1 (https=)
JP (1) JP6149104B2 (https=)
KR (1) KR102086389B1 (https=)
CN (1) CN104411704B (https=)
AP (1) AP2014008089A0 (https=)
AU (1) AU2013258107B2 (https=)
BR (1) BR112014027564B1 (https=)
CA (1) CA2872726C (https=)
CL (2) CL2014003003A1 (https=)
CO (1) CO7121324A2 (https=)
CR (1) CR20140514A (https=)
CU (1) CU20140128A7 (https=)
DK (1) DK2847183T3 (https=)
DO (1) DOP2014000254A (https=)
EA (1) EA027804B1 (https=)
ES (1) ES2641205T3 (https=)
HR (1) HRP20171321T1 (https=)
HU (1) HUE034430T2 (https=)
IL (1) IL235441A (https=)
LT (1) LT2847183T (https=)
MX (1) MX350519B (https=)
MY (1) MY184577A (https=)
NZ (1) NZ701661A (https=)
PE (1) PE20142453A1 (https=)
PH (1) PH12014502482A1 (https=)
PL (1) PL2847183T3 (https=)
PT (1) PT2847183T (https=)
RS (1) RS56255B1 (https=)
SG (2) SG10201609319YA (https=)
SI (1) SI2847183T1 (https=)
TN (1) TN2014000469A1 (https=)
UA (1) UA116349C2 (https=)
WO (1) WO2013167552A1 (https=)
ZA (1) ZA201408571B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2639716B2 (ja) 1988-12-14 1997-08-13 横浜ゴム株式会社 タイヤ成形装置に於けるグリーンタイヤの搬送装置
JOP20170103A1 (ar) * 2016-05-03 2017-11-03 Bayer Pharma AG عملية لتحضير مشتقات 1-فنيل-1، 2، 4-تريازول مستبدلة بـ 5-هيدروكسي ألكيل
CN108084099B (zh) * 2017-12-20 2019-01-29 天驰药业有限公司 一种1,2,3-三氮唑化合物的合成方法
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents
EP3888684A1 (en) 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition having improved voluntary acceptance
JP7710897B2 (ja) * 2021-06-01 2025-07-22 三菱ガス化学ネクスト株式会社 1-アルキル-5-ヒドロキシピラゾールの製造方法
CN114264752B (zh) * 2021-12-29 2023-08-15 北京金城泰尔制药有限公司 溴乙酸甲酯的检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135184A (da) 1983-03-03 1984-10-10 Riker Laboratories Inc Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4752910A (en) 1984-10-30 1988-06-21 Prime Computer, Inc. Method and apparatus for continuous after-imaging
UY27813A1 (es) * 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
TWI335913B (en) 2002-11-15 2011-01-11 Vertex Pharma Diaminotriazoles useful as inhibitors of protein kinases
EP1682494A4 (en) * 2003-10-30 2006-11-08 Merck & Co Inc ARALKYLAMINES AS MODULATORS OF CANNABINOID RECEPTORS
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
DE102008020113A1 (de) 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituierte Dihydropyrazolone und ihre Verwendung
WO2006114706A1 (en) 2005-04-26 2006-11-02 Pfizer Limited Triazole derivatives as vasopressin antagonists
CA2608718A1 (en) 2005-05-18 2006-11-23 Pfizer Limited 1, 2, 4-triazole derivatives as vasopressin antagonists
DE102006050516A1 (de) * 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dihydropyrazolone und ihre Verwendung
DE102010041236A1 (de) * 2010-09-23 2012-03-29 Osram Ag Optoelektronisches Halbleiterbauelement
DE102010044131A1 (de) * 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat

Also Published As

Publication number Publication date
US10301289B2 (en) 2019-05-28
JP2015516403A (ja) 2015-06-11
CA2872726C (en) 2020-07-07
CO7121324A2 (es) 2014-11-20
ES2641205T3 (es) 2017-11-08
BR112014027564B1 (pt) 2022-05-03
SG11201407043PA (en) 2014-12-30
HRP20171321T1 (hr) 2017-10-20
ZA201408571B (en) 2016-03-30
AU2013258107A1 (en) 2014-11-27
CA2872726A1 (en) 2013-11-14
PE20142453A1 (es) 2015-01-17
CR20140514A (es) 2014-12-02
EA201492032A1 (ru) 2015-04-30
EP2847183B1 (de) 2017-06-21
SI2847183T1 (sl) 2017-10-30
UA116349C2 (uk) 2018-03-12
AU2013258107B2 (en) 2017-06-22
PH12014502482A1 (en) 2015-01-12
IL235441A (en) 2017-09-28
KR20150018534A (ko) 2015-02-23
LT2847183T (lt) 2017-09-25
AP2014008089A0 (en) 2014-11-30
NZ701661A (en) 2016-08-26
CL2014003003A1 (es) 2015-02-13
EP2847183A1 (de) 2015-03-18
MX2014013448A (es) 2014-12-08
HK1208027A1 (en) 2016-02-19
CL2016001165A1 (es) 2016-12-02
BR112014027564A2 (https=) 2017-08-22
CU20140128A7 (es) 2015-03-30
CN104411704A (zh) 2015-03-11
MX350519B (es) 2017-09-08
US20150087827A1 (en) 2015-03-26
DK2847183T3 (en) 2017-10-02
RS56255B1 (sr) 2017-11-30
PT2847183T (pt) 2017-10-02
KR102086389B1 (ko) 2020-03-09
PL2847183T3 (pl) 2017-11-30
TN2014000469A1 (en) 2016-03-30
CN104411704B (zh) 2017-12-22
JP6149104B2 (ja) 2017-06-14
HUE034430T2 (en) 2018-02-28
EA027804B1 (ru) 2017-09-29
WO2013167552A1 (de) 2013-11-14
SG10201609319YA (en) 2016-12-29
DOP2014000254A (es) 2016-01-31

Similar Documents

Publication Publication Date Title
MY184577A (en) Method for the preparation of triazole compounds
CR20140038A (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-alquiniloxi-etil}-1h-[1,2,4]triazol sustituidos
NZ595553A (en) VINYL INDAZOLYL COMPOUND; (E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol
CL2014000384A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-2-alquinil/alquenil-etil)-1h-(1,2,4) triazol sustituidos; proceso para preparar dichos compuestos; composiciones agroquímicas.
TN2012000347A1 (en) 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
SA113340696B1 (ar) تصنيع 2-(5-برومو-4-(4-سيكلو بروبيل نافثالين-1-يل)-4 h-1، 2، 4- ترازول-3- يل ثيو) حمض أسيتيك
MX2020005818A (es) Triazol azoles de acido ciclohexilo como antagonistas de acido lisofosfatidico (lpa).
MX2013014348A (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-feni]-2 -alcoxi-2-ciclil-etil}-1h-[1,2,4]triazol sustituidos.
MX381205B (es) Acidos de carbamoiloximetil triazol ciclohexilo como antagonistas de acido lisofosfatidico (lpa).
CL2014000202A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-3-metil-butil)-1h(1,2,4)triazol sustituidos; proceso para preparar dicho compuesto; uso de dichos compuestos para combatir hongos fitopatogenos.
MX2015008927A (es) Proceso para la preparacion de oxiranos y triazoles sustituidos.
GEP20156262B (en) Fungicidal pyrazoles and their mixtures
NZ588721A (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
NZ610614A (en) Substituted sodium-1h-pyrazole-5-olate
NZ624636A (en) Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
MY185203A (en) Method for producing 4-[5-(pyridin-4-yl)-1h-1,2,4-triazol-3-yl]pyridine-2-carbonitrile, and intermediate thereof
CL2018003107A1 (es) Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo
MY177721A (en) 6-((s)-1-{1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl}-ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist
MX2021002132A (es) Metodo para preparar 2-[(3r)-3--metilmofolin--4-il]-4-(1-metil-1h- pirazol-5-il)-8-(1h-pirazol-5-il)-1,7-naftiridina.
EP3233824A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3- (methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
EP3233079A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
TH152857A (th) วิธีการสำหรับการเตรียมของสารประกอบไตรอาซอล
IL244933A0 (en) Pharmaceutical dosage forms containing sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(3,2,1-1h-triazol-1-yl)-1h-pyrazol-5-olate
IL304456A (en) Methods for preparing 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazol-3-carboxylic acid
TR201105728A2 (tr) 2-(2,4-diflorofenil)-1,3-bis(1h-1,2,4-triazol-1-il)propan-2 ol'ün farmasotik bir bileşim içerisinde kullanımı.